Peer-influenced content. Sources you trust. No registration required. This is HCN.

Psychiatrist.comPosttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure

ℹ️ Observational Association Only Evidence

Researchers analyzed 15,570 benzodiazepine-naïve adults exposed to a mass-trauma event and tracked PTSD diagnoses over 12 months. Early or delayed short-term benzodiazepine use was not associated with increased PTSD risk, while persistent use was associated with higher PTSD incidence.


Clinical Considerations

  • PTSD incidence was 5.0% overall, with similar 12-month rates among nonpurchasers, early purchasers, and late purchasers.
  • Early benzodiazepine use showed no increased PTSD risk after adjustment (HR 0.98, 95% CI 0.80–1.20).
  • Persistent users demonstrated higher PTSD risk (HR 1.60 to 2.07), whereas discontinued users did not.
  • Among highly trauma-exposed Gaza border residents, benzodiazepine purchasers had lower PTSD risk than nonpurchasers.

Practice Applications

  • Interpret short-term posttrauma benzodiazepine use as not associated with increased PTSD risk in this cohort.
  • Recognize that persistent benzodiazepine use may identify patients at elevated PTSD risk.
  • Monitor ongoing benzodiazepine use patterns following traumatic exposure.
  • Avoid inferring a protective effect because observational findings did not establish causality.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form